Marcello Curvietto

1.5k total citations
29 papers, 618 citations indexed

About

Marcello Curvietto is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Marcello Curvietto has authored 29 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Marcello Curvietto's work include Melanoma and MAPK Pathways (15 papers), Cancer Immunotherapy and Biomarkers (14 papers) and CAR-T cell therapy research (10 papers). Marcello Curvietto is often cited by papers focused on Melanoma and MAPK Pathways (15 papers), Cancer Immunotherapy and Biomarkers (14 papers) and CAR-T cell therapy research (10 papers). Marcello Curvietto collaborates with scholars based in Italy, United States and Malaysia. Marcello Curvietto's co-authors include Ester Simeone, Paolo A. Ascierto, Antonio Maria Grimaldi, Nicola Mozzillo, Assunta Esposito, Marco Palla, Diana Giannarelli, Giuseppe Palmieri, Miriam Paone and Corrado Caracò and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Marcello Curvietto

29 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcello Curvietto Italy 10 434 239 180 108 59 29 618
Gayathri Anandappa United Kingdom 8 392 0.9× 300 1.3× 183 1.0× 105 1.0× 26 0.4× 18 698
Sophia Frentzas Australia 14 388 0.9× 121 0.5× 276 1.5× 152 1.4× 23 0.4× 65 737
Assunta Esposito Italy 9 423 1.0× 214 0.9× 105 0.6× 113 1.0× 14 0.2× 21 517
J. J. Mahany United States 9 541 1.2× 487 2.0× 205 1.1× 88 0.8× 35 0.6× 22 766
Julia Katharina Schwarze Belgium 15 491 1.1× 378 1.6× 202 1.1× 102 0.9× 23 0.4× 44 745
Andrew Cannon United States 10 245 0.6× 131 0.5× 252 1.4× 50 0.5× 25 0.4× 24 501
Yunxin Lai China 9 504 1.2× 250 1.0× 227 1.3× 121 1.1× 61 1.0× 10 779
Earl Avramis United States 12 711 1.6× 457 1.9× 347 1.9× 100 0.9× 21 0.4× 15 986
Jii Bum Lee South Korea 12 322 0.7× 171 0.7× 187 1.0× 140 1.3× 14 0.2× 47 545
Elizabeth Seja United States 10 770 1.8× 682 2.9× 206 1.1× 73 0.7× 25 0.4× 12 963

Countries citing papers authored by Marcello Curvietto

Since Specialization
Citations

This map shows the geographic impact of Marcello Curvietto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcello Curvietto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcello Curvietto more than expected).

Fields of papers citing papers by Marcello Curvietto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcello Curvietto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcello Curvietto. The network helps show where Marcello Curvietto may publish in the future.

Co-authorship network of co-authors of Marcello Curvietto

This figure shows the co-authorship network connecting the top 25 collaborators of Marcello Curvietto. A scholar is included among the top collaborators of Marcello Curvietto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcello Curvietto. Marcello Curvietto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simeone, Ester, Giosuè Scognamiglio, Mariaelena Capone, et al.. (2021). A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation. Journal of Translational Medicine. 19(1). 17–17. 5 indexed citations
2.
Giunta, Emilio Francesco, Marcello Curvietto, Davide Bosso, et al.. (2021). Epigenetic Regulation in Melanoma: Facts and Hopes. Cells. 10(8). 2048–2048. 29 indexed citations
3.
Simeone, Ester, Antonio Maria Grimaldi, Lucia Festino, et al.. (2019). Nivolumab for the treatment of small cell lung cancer. Expert Review of Respiratory Medicine. 14(1). 5–13. 6 indexed citations
4.
Capasso, Arturo, Antonio Nardone, Sandro Pignata, et al.. (2019). Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology. PLoS ONE. 14(1). e0210330–e0210330. 8 indexed citations
5.
Simeone, Ester, Antonio Maria Grimaldi, Lucia Festino, et al.. (2017). Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma. OncoImmunology. 6(3). e1283462–e1283462. 30 indexed citations
6.
7.
Queirolo, Paola, Francesco Spagnolo, Virginia Picasso, et al.. (2016). Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib. Oncotarget. 9(15). 12408–12417. 11 indexed citations
8.
Mozzillo, Nicola, Ester Simeone, Marcello Curvietto, et al.. (2015). Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy. OncoImmunology. 4(6). e1008842–e1008842. 55 indexed citations
9.
Grimaldi, Antonio Maria, Ester Simeone, Lucia Festino, et al.. (2015). Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P186–P186. 6 indexed citations
10.
11.
Ascierto, Paolo A., Keith T. Flaherty, Paola Queirolo, et al.. (2014). Phase I-II study of the combination vemurafenib plus peg-interferon in advanced melanoma patients harboring the V600BRAF mutation.. Journal of Clinical Oncology. 32(15_suppl). TPS9105–TPS9105. 3 indexed citations
12.
Grimaldi, Antonio Maria, Ester Simeone, Diana Giannarelli, et al.. (2014). Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy. OncoImmunology. 3(5). e28780–e28780. 290 indexed citations
13.
Grimaldi, Antonio Maria, Ester Simeone, Diana Giannarelli, et al.. (2014). Efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg. Journal of Translational Medicine. 12(Suppl 1). O6–O6. 3 indexed citations
14.
Simeone, Ester, Antonio Maria Grimaldi, Assunta Esposito, et al.. (2014). Serious haematological toxicity during and after ipilimumab treatment: a case series. Journal of Medical Case Reports. 8(1). 240–240. 41 indexed citations
15.
Bifulco, Carlo, Mariaelena Capone, Gabriele Madonna, et al.. (2014). MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab. Journal of Translational Medicine. 12(Suppl 1). P11–P11. 13 indexed citations
16.
Ascierto, Paolo A., Ester Simeone, Antonio Maria Grimaldi, et al.. (2013). Do BRAF inhibitors select for populations with different disease progression kinetics?. Journal of Translational Medicine. 11(1). 61–61. 18 indexed citations
17.
Grimaldi, Antonio Maria, Ester Simeone, Diana Giannarelli, et al.. (2013). The abscopal effect: efficacy of radiotherapy in patients on progression after treatment with ipilimumab 3 mg/kg. Journal for ImmunoTherapy of Cancer. 1(S1). 3 indexed citations
18.
Simeone, Ester, Giusy Gentilcore, Corrado Caracò, et al.. (2013). Combination therapy with ipilimumab and electrochemotherapy: Preliminary efficacy results and correlation with immunologic parameters.. Journal of Clinical Oncology. 31(15_suppl). e20031–e20031. 3 indexed citations
19.
Simeone, Ester, Giusy Gentilcore, Antonio Daponte, et al.. (2012). Immunological and biological changes during ipilimumab (Ipi) treatment and their correlation with clinical response and survival.. Journal of Clinical Oncology. 30(15_suppl). 8573–8573. 11 indexed citations
20.
Simeone, Ester, Giusy Gentilcore, Alessandro Esposito, et al.. (2011). 9322 POSTER Immunological and Biological Changes and Their Correlation With Clinical Response and Survival During Ipilimumab in Metastatic Melanoma Compassionate Use Program. European Journal of Cancer. 47. S658–S659. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gayathri Anandappa Breakdown of academic impact, for papers by Sophia Frentzas Breakdown of academic impact, for papers by Assunta Esposito Breakdown of academic impact, for papers by J. J. Mahany Breakdown of academic impact, for papers by Julia Katharina Schwarze Breakdown of academic impact, for papers by Andrew Cannon Breakdown of academic impact, for papers by Yunxin Lai Breakdown of academic impact, for papers by Earl Avramis Breakdown of academic impact, for papers by Jii Bum Lee Breakdown of academic impact, for papers by Elizabeth Seja
Rankless by CCL
2026